Serum SP-D enrichment is observed in pulmonary allergies (342–346) and allergic rhinitis (219), which is considered to be a manifestation of the same underlying disease processes as asthma (347), and basic research has demonstrated a link between SP-D and T helper 2 cell (Th2)-mediated inflammation. Here, SFTPD is linked to asthma.